NSE - Delayed Quote INR

Tatva Chintan Pharma Chem Limited (TATVA.NS)

Compare
914.95 -30.95 (-3.27%)
At close: October 25 at 3:30 PM GMT+5:30
Currency in INR All numbers in thousands
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Total Revenue
3,846,040.00
3,935,040.00
4,236,120.00
4,312,930.00
2,968,570.00
--
Cost of Revenue
1,731,330.00
1,741,820.00
2,261,010.00
2,076,780.00
1,583,580.00
--
Gross Profit
2,114,710.00
2,193,220.00
1,975,110.00
2,236,150.00
1,384,990.00
--
Operating Expense
1,782,610.00
1,767,310.00
1,464,850.00
1,228,100.00
784,640.00
--
Operating Income
332,100.00
425,910.00
510,260.00
1,008,050.00
600,350.00
--
Net Non Operating Interest Income Expense
-39,200.00
-65,320.00
-84,040.00
-5,650.00
-40,880.00
--
Pretax Income
369,570.00
435,680.00
447,790.00
1,041,210.00
606,960.00
--
Tax Provision
108,980.00
132,140.00
-7,080.00
82,470.00
84,340.00
--
Net Income Common Stockholders
260,590.00
303,540.00
454,870.00
958,740.00
522,620.00
--
Diluted NI Available to Com Stockholders
260,590.00
303,540.00
454,870.00
958,740.00
522,620.00
--
Basic EPS
11.20
13.26
20.52
44.59
23.58
--
Diluted EPS
11.20
13.26
20.52
44.59
23.58
--
Basic Average Shares
23,192.63
22,891.40
22,167.15
21,499.10
22,165.06
--
Diluted Average Shares
23,192.63
22,891.40
22,167.15
21,499.10
22,165.06
--
Rent Expense Supplemental
--
--
18,780.00
11,400.00
14,480.00
11,350.00
Total Expenses
3,513,940.00
3,509,130.00
3,725,860.00
3,304,880.00
2,368,220.00
--
Net Income from Continuing & Discontinued Operation
260,590.00
303,540.00
454,870.00
958,740.00
522,620.00
--
Normalized Income
260,590.00
303,540.00
479,979.00
959,596.34
523,102.22
--
Interest Income
--
--
53,340.00
46,680.00
3,590.00
5,170.00
Interest Expense
39,200.00
65,320.00
84,040.00
43,510.00
39,850.00
--
Net Interest Income
-39,200.00
-65,320.00
-84,040.00
-5,650.00
-40,880.00
--
EBIT
408,770.00
501,000.00
531,830.00
1,084,720.00
646,810.00
--
EBITDA
671,350.00
757,050.00
627,380.00
1,166,520.00
714,140.00
--
Reconciled Cost of Revenue
1,731,330.00
1,741,820.00
2,261,010.00
2,076,780.00
1,583,580.00
--
Reconciled Depreciation
262,580.00
256,050.00
95,550.00
81,800.00
67,330.00
--
Net Income from Continuing Operation Net Minority Interest
260,590.00
303,540.00
454,870.00
958,740.00
522,620.00
--
Total Unusual Items Excluding Goodwill
--
--
-35,870.00
-930.00
-560.00
--
Total Unusual Items
--
--
-35,870.00
-930.00
-560.00
--
Normalized EBITDA
671,350.00
757,050.00
663,250.00
1,167,450.00
714,700.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
--
--
-10,761.00
-73.66
-77.78
--
3/31/2020 - 7/29/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers